Publications

• Toll-like receptor 7 (TLR7)-mediated antiviral response protects mice from lethal SARS-CoV-2 infection.
  J Virol Volume: 99 Page(s): e0166824
  05/20/2025 Authors: Ghimire R; Shrestha R; Amaradhi R; Liu L; More S; Ganesh T; Ford AK; Channappanavar R
• Bisbiguanide analogs induce mitochondrial stress to inhibit lung cancer cell invasion.
  iScience Volume: 27 Page(s): 109591
  04/19/2024 Authors: Knippler CM; Arnst JL; Robinson IE; Matsuk V; Khatib TO; Harvey RD; Shanmugam M; Mouw JK; Fu H; Ganesh T
• Novel NADPH Oxidase-2 Inhibitors as Potential Anti-Inflammatory and Neuroprotective Agents.
  Antioxidants (Basel) Volume: 12
  08/23/2023 Authors: Juric M; Rawat V; Amaradhi R; Zielonka J; Ganesh T
• Targeting EP2 Receptor for Drug Discovery: Strengths, Weaknesses, Opportunities, and Threats (SWOT) Analysis.
  J Med Chem Volume: 66 Page(s): 9313 - 9324
  07/27/2023 Authors: Ganesh T
• Preclinical development of an EP2 antagonist for post-seizure cognitive deficits.
  Neuropharmacology Volume: 224 Page(s): 109356
  02/15/2023 Authors: Varvel NH; Amaradhi R; Espinosa-Garcia C; Duddy S; Franklin R; Banik A; Alemn-Ruiz C; Blackmer-Raynolds L; Wang W; Honore T
• Temporal Expression of Neuroinflammatory and Oxidative Stress Markers and Prostaglandin E2 Receptor EP2 Antagonist Effect in a Rat Model of Epileptogenesis.
  ACS Pharmacol Transl Sci Volume: 6 Page(s): 128 - 138
  01/13/2023 Authors: Rawat V; Eastman CL; Amaradhi R; Banik A; Fender JS; Dingledine RJ; D'Ambrosio R; Ganesh T
• Pharmacological antagonism of EP2 receptor does not modify basal cardiovascular and respiratory function, blood cell counts, and bone morphology in animal models.
  Biomed Pharmacother Volume: 147 Page(s): 112646
  03/01/2022 Authors: Rawat V; Banik A; Amaradhi R; Rojas A; Taval S; Nagy T; Dingledine R; Ganesh T
• Second-Generation Prostaglandin Receptor EP2 Antagonist, TG8-260, with High Potency, Selectivity, Oral Bioavailability, and Anti-Inflammatory Properties.
  ACS Pharmacol Transl Sci Volume: 5 Page(s): 118 - 133
  02/11/2022 Authors: Amaradhi R; Mohammed S; Banik A; Franklin R; Dingledine R; Ganesh T
• Microbial metabolite delta-valerobetaine is a diet-dependent obesogen.
  Nat Metab Volume: 3 Page(s): 1694 - 1705
  12/01/2021 Authors: Liu KH; Owens JA; Saeedi B; Cohen CE; Bellissimo MP; Naudin C; Darby T; Druzak S; Maner-Smith K; Orr M
• Prostaglandin EP2 receptor antagonist ameliorates neuroinflammation in a two-hit mouse model of Alzheimer's disease.
  J Neuroinflammation Volume: 18 Page(s): 273
  11/20/2021 Authors: Banik A; Amaradhi R; Lee D; Sau M; Wang W; Dingledine R; Ganesh T
• A Novel Second-Generation EP2 Receptor Antagonist Reduces Neuroinflammation and Gliosis After Status Epilepticus in Rats.
  Neurotherapeutics Volume: 18 Page(s): 1207 - 1225
  04/01/2021 Authors: Rojas A; Amaradhi R; Banik A; Jiang C; Abreu-Melon J; Wang S; Dingledine R; Ganesh T
• Peripheral Myeloid Cell EP2 Activation Contributes to the Deleterious Consequences of Status Epilepticus.
  J Neurosci Volume: 41 Page(s): 1105 - 1117
  02/03/2021 Authors: Varvel NH; Espinosa-Garcia C; Hunter-Chang S; Chen D; Biegel A; Hsieh A; Blackmer-Raynolds L; Ganesh T; Dingledine R
• Quinazolin-derived myeloperoxidase inhibitor suppresses influenza A virus-induced reactive oxygen species, pro-inflammatory mediators and improves cell survival.
  PLoS One Volume: 16 Page(s): e0254632
  01/01/2021 Authors: De La Cruz JA; Ganesh T; Diebold BA; Cao W; Hofstetter A; Singh N; Kumar A; McCoy J; Ranjan P; Smith SME
• Azaindole therapeutic agents.
  Bioorg Med Chem Volume: 28 Page(s): 115830
  12/15/2020 Authors: Motati DR; Amaradhi R; Ganesh T
• Inhibition of the prostaglandin EP2 receptor prevents long-term cognitive impairment in a model of systemic inflammation.
  Brain Behav Immun Health Volume: 8 Page(s): 100132
  10/01/2020 Authors: Jiang C; Caskurlu A; Ganesh T; Dingledine R
• Modulating neuroinflammation and oxidative stress to prevent epilepsy and improve outcomes after traumatic brain injury.
  Neuropharmacology Volume: 172 Page(s): 107907
  08/01/2020 Authors: Eastman CL; D'Ambrosio R; Ganesh T
• An Agonist Dependent Allosteric Antagonist of Prostaglandin EP2 Receptors.
  ACS Chem Neurosci Volume: 11 Page(s): 1436 - 1446
  05/20/2020 Authors: Jiang C; Amaradhi R; Ganesh T; Dingledine R
• A Noncompetitive and Selective Prostaglandin EP2 Antagonist with Anti-inflammatory Property
  Volume: 34
  04/01/2020 Authors: Jiang C; Amaradhi R; Ganesh T; Dingledine R
• Potent, Selective, Water Soluble, Brain-Permeable EP2 Receptor Antagonist for Use in Central Nervous System Disease Models.
  J Med Chem Volume: 63 Page(s): 1032 - 1050
  02/13/2020 Authors: Amaradhi R; Banik A; Mohammed S; Patro V; Rojas A; Wang W; Motati DR; Dingledine R; Ganesh T
• A rat model of organophosphate-induced status epilepticus and the beneficial effects of EP2 receptor inhibition.
  Neurobiol Dis Volume: 133 Page(s): 104399
  01/01/2020 Authors: Rojas A; Ganesh T; Wang W; Wang J; Dingledine R
• Novel Microglia Cell Line Expressing the Human EP2 Receptor.
  ACS Chem Neurosci Volume: 10 Page(s): 4280 - 4292
  10/16/2019 Authors: Rojas A; Banik A; Chen D; Flood K; Ganesh T; Dingledine R
• Development of water soluble, brain permeable EP2 receptor antagonist: Lead-optimization and in vitro proof-of-concept studies
  Volume: 257
  03/31/2019 Authors: Amaradhi R; Banik A; Mohammed S; Patro V; Rojas A; Wang W; Dingledine R; Ganesh T
• The COX-2/prostanoid signaling cascades in seizure disorders.
  Expert Opin Ther Targets Volume: 23 Page(s): 1 - 13
  01/01/2019 Authors: Rojas A; Chen D; Ganesh T; Varvel NH; Dingledine R
• 5xFAD Mice Display Sex-Dependent Inflammatory Gene Induction During the Prodromal Stage of Alzheimer's Disease.
  J Alzheimers Dis Volume: 70 Page(s): 1259 - 1274
  01/01/2019 Authors: Manji Z; Rojas A; Wang W; Dingledine R; Varvel NH; Ganesh T
• Peripherally Restricted, Highly Potent, Selective, Aqueous-Soluble EP2 Antagonist with Anti-Inflammatory Properties.
  Mol Pharm Volume: 15 Page(s): 5809 - 5817
  12/03/2018 Authors: Ganesh T; Banik A; Dingledine R; Wang W; Amaradhi R
• Discovery of 2-Piperidinyl Phenyl Benzamides and Trisubstituted Pyrimidines as Positive Allosteric Modulators of the Prostaglandin Receptor EP2.
  ACS Chem Neurosci Volume: 9 Page(s): 699 - 707
  04/18/2018 Authors: Jiang J; Van TM; Ganesh T; Dingledine R
• Prostaglandin dehydrogenase is a target for successful induction of cervical ripening.
  Proc Natl Acad Sci U S A Volume: 114 Page(s): E6427 - E6436
  08/01/2017 Authors: Kishore AH; Liang H; Kanchwala M; Xing C; Ganesh T; Akgul Y; Posner B; Ready JM; Markowitz SD; Word RA
• Ethylatropine Bromide as a Peripherally Restricted Muscarinic Antagonist.
  ACS Chem Neurosci Volume: 8 Page(s): 712 - 717
  04/19/2017 Authors: Rojas A; Ganesh T; Walker A; Dingledine R
• Inhibition of pilocarpine-induced fluid secretion by ethylatropine bromide
  Volume: 253
  04/02/2017 Authors: Ganesh T; Rojas A; Walker A; Dingledine R
• Structure Activity Relationship (SAR) studies of EP2 receptor antagonists
  Volume: 253
  04/02/2017 Authors: Ganesh T; Dingledine R
• Inhibition of the prostaglandin E2 receptor EP2 prevents status epilepticus-induced deficits in the novel object recognition task in rats.
  Neuropharmacology Volume: 110 Page(s): 419 - 430
  11/01/2016 Authors: Rojas A; Ganesh T; Manji Z; O'neill T; Dingledine R
• Thioxo-dihydroquinazolin-one Compounds as Novel Inhibitors of Myeloperoxidase.
  ACS Med Chem Lett Volume: 6 Page(s): 1047 - 1052
  10/08/2015 Authors: Li Y; Ganesh T; Diebold BA; Zhu Y; McCoy JW; Smith SME; Sun A; Lambeth JD
• EP2 Receptor Signaling Regulates Microglia Death.
  Mol Pharmacol Volume: 88 Page(s): 161 - 170
  07/01/2015 Authors: Fu Y; Yang M-S; Jiang J; Ganesh T; Joe E; Dingledine R
• Evaluation of WO 2012/177618 A1 and US-2014/0179750 A1: novel small molecule antagonists of prostaglandin-E2 receptor EP2.
  Expert Opin Ther Pat Volume: 25 Page(s): 837 - 844
  07/01/2015 Authors: Ganesh T
• Inhibition of the prostaglandin EP2 receptor is neuroprotective and accelerates functional recovery in a rat model of organophosphorus induced status epilepticus.
  Neuropharmacology Volume: 93 Page(s): 15 - 27
  06/01/2015 Authors: Rojas A; Ganesh T; Lelutiu N; Gueorguieva P; Dingledine R
• Therapeutic window for cyclooxygenase-2 related anti-inflammatory therapy after status epilepticus.
  Neurobiol Dis Volume: 76 Page(s): 126 - 136
  04/01/2015 Authors: Jiang J; Yang M-S; Quan Y; Gueorguieva P; Ganesh T; Dingledine R
• Context-dependent GluN2B-selective inhibitors of NMDA receptor function are neuroprotective with minimal side effects.
  Neuron Volume: 85 Page(s): 1305 - 1318
  03/18/2015 Authors: Yuan H; Myers SJ; Wells G; Nicholson KL; Swanger SA; Lyuboslavsky P; Tahirovic YA; Menaldino DS; Ganesh T; Wilson LJ
• Dual EZH2 and EHMT2 histone methyltransferase inhibition increases biological efficacy in breast cancer cells.
  Clin Epigenetics Volume: 7 Page(s): 84
  01/01/2015 Authors: Curry E; Green I; Chapman-Rothe N; Shamsaei E; Kandil S; Cherblanc FL; Payne L; Bell E; Ganesh T; Srimongkolpithak N
• Development of second generation EP2 antagonists with high selectivity.
  Eur J Med Chem Volume: 82 Page(s): 521 - 535
  07/23/2014 Authors: Ganesh T; Jiang J; Dingledine R
• Prostanoid receptor EP2 as a therapeutic target.
  J Med Chem Volume: 57 Page(s): 4454 - 4465
  06/12/2014 Authors: Ganesh T
• High-throughput assays for superoxide and hydrogen peroxide: design of a screening workflow to identify inhibitors of NADPH oxidases.
  J Biol Chem Volume: 289 Page(s): 16176 - 16189
  06/06/2014 Authors: Zielonka J; Cheng G; Zielonka M; Ganesh T; Sun A; Joseph J; Michalski R; O'Brien WJ; Lambeth JD; Kalyanaraman B
• Lead optimization studies of cinnamic amide EP2 antagonists.
  J Med Chem Volume: 57 Page(s): 4173 - 4184
  05/22/2014 Authors: Ganesh T; Jiang J; Yang M-S; Dingledine R
• Synthesis of isotopically labeled epothilones.
  J Labelled Comp Radiopharm Volume: 57 Page(s): 78 - 81
  02/01/2014 Authors: Ganesh T; Brodie PJ; Banerjee A; Bane S; Kingston DGI
• Cyclooxygenase-2 in epilepsy.
  Epilepsia Volume: 55 Page(s): 17 - 25
  01/01/2014 Authors: Rojas A; Jiang J; Ganesh T; Yang M-S; Lelutiu N; Gueorguieva P; Dingledine R
• Discovery and characterization of carbamothioylacrylamides as EP2 selective antagonists.
  ACS Med Chem Lett Volume: 4 Page(s): 616 - 621
  07/11/2013 Authors: Ganesh T; Jiang J; Shashidharamurthy R; Dingledine R
• A novel quinazolin-derived reactive oxygen species-inhibitor suppresses influenza A virus-induced inflammatory mediators and leads to enhanced survival in mice
  Volume: 190
  05/01/2013 Authors: Gangappa S; De La Cruz J; Ganesh T; Diebold B; Cao W; Smith S; Taylor A; Singh N; Hofstetter A; Kumar A
• Inhibition of the prostaglandin receptor EP2 following status epilepticus reduces delayed mortality and brain inflammation.
  Proc Natl Acad Sci U S A Volume: 110 Page(s): 3591 - 3596
  02/26/2013 Authors: Jiang J; Quan Y; Ganesh T; Pouliot WA; Dudek FE; Dingledine R
• High-Throughput Screening (HTS) Assay for Identifying Potent and Selective Small-Molecule Inhibitors of NADPH Oxidases
  Volume: 53 Page(s): S122 - S122
  11/01/2012 Authors: Zielonka J; Zielonka M; Ganesh T; Sun A; Cheng G; Michalski R; O'Brien W; Lambeth D; Kalyanaraman B
• Ebselen and congeners inhibit NADPH oxidase 2-dependent superoxide generation by interrupting the binding of regulatory subunits.
  Chem Biol Volume: 19 Page(s): 752 - 763
  06/22/2012 Authors: Smith SME; Min J; Ganesh T; Diebold B; Kawahara T; Zhu Y; McCoy J; Sun A; Snyder JP; Fu H
• Small molecule antagonist reveals seizure-induced mediation of neuronal injury by prostaglandin E2 receptor subtype EP2.
  Proc Natl Acad Sci U S A Volume: 109 Page(s): 3149 - 3154
  02/21/2012 Authors: Jiang J; Ganesh T; Du Y; Quan Y; Serrano G; Qui M; Speigel I; Rojas A; Lelutiu N; Dingledine R
• Withaferin A inhibits breast cancer invasion and metastasis at sub-cytotoxic doses by inducing vimentin disassembly and serine 56 phosphorylation.
  Int J Cancer Volume: 129 Page(s): 2744 - 2755
  12/01/2011 Authors: Thaiparambil JT; Bender L; Ganesh T; Kline E; Patel P; Liu Y; Tighiouart M; Vertino PM; Harvey RD; Garcia A
• Inhibitors of NADPH Oxidase Decrease Peroxynitrite Formation in Activated Macrophages
  Volume: 51 Page(s): S53 - S53
  11/01/2011 Authors: Zielonka J; Zielonka M; Ganesh T; Sun A; Lambeth D; Kalyanaraman B
• Identification and Characterization of Novel NADPH Oxidase Inhibitors for Suppression of Influenza a virus-induced Lung Inflammation
  Volume: 51 Page(s): S108 - S108
  11/01/2011 Authors: Sun A; De la Cruz J; Ganesh T; Taylor A; Diebold B; Smith SME; Zhu Y; McCoy J; Gangappa S; Lambeth JD
• Ebselen Congeners Inhibit NADPH-oxidase 2 (Nox2)-Dependent Superoxide Generation by Interrupting the Binding of Regulatory Subunits
  Volume: 51 Page(s): S98 - S98
  11/01/2011 Authors: Smith SME; Min J; Ganesh T; Kawahara T; Diebold B; Zhu Y; McCoy J; Sun A; Snyder JP; Fu H
• Lipocalin-2 Deficiency Increases Gut Bacterial Burden and Excerbates Dextran Sulfate Sodium (DSS) Induced Murine Colitis
  Volume: 140 Page(s): S496 - S496
  05/01/2011 Authors: Aitken JD; Carvalho FA; Fifadara N; Ganesh T; Gewirtz AT; Vijay-Kumar M
• Withaferin A inhibits breast cancer invasion and metastasis at subcytotoxic doses by inducing vimentin disassembly and serine 56 phosphorylation
  CANCER RESEARCH Volume: 71
  04/15/2011 Authors: Thaiparambil JT; Bender L; Ganesh T; Kline E; Patel P; Liu Y; Tighiouart M; Vertino PM; Harvey RD; Garcia A
• Adding a lysine mimic in the design of potent inhibitors of histone lysine methyltransferases.
  J Mol Biol Volume: 400 Page(s): 1 - 7
  07/02/2010 Authors: Chang Y; Ganesh T; Horton JR; Spannhoff A; Liu J; Sun A; Zhang X; Bedford MT; Shinkai Y; Snyder JP
• Novel epothilone lactones by an unusual diversion of the Grubbs' metathesis reaction.
  Chem Commun (Camb) Volume: 46 Page(s): 2019 - 2021
  03/28/2010 Authors: Chen Q-H; Ganesh T; Jiang Y; Banerjee A; Sharma S; Bane S; Snyder JP; Kingston DGI
• Neuroprotection by selective allosteric potentiators of the EP2 prostaglandin receptor.
  Proc Natl Acad Sci U S A Volume: 107 Page(s): 2307 - 2312
  02/02/2010 Authors: Jiang J; Ganesh T; Du Y; Thepchatri P; Rojas A; Lewis I; Kurtkaya S; Li L; Qui M; Serrano G
• Vimentin: A Novel Chemopreventive Target for Breast Cancer Metastasis
  Volume: 69 Page(s): 786S - 786S
  12/15/2009 Authors: Thaiparambil JT; Bender L; Kline E; Ganesh T; Snyder JP; Liotta D; Marcus A
• Cancer and virus leads by HTS, chemical design and SEA data mining.
  Curr Top Med Chem Volume: 9 Page(s): 1159 - 1171
  01/01/2009 Authors: Thepchatri P; Min J; Ganesh T; Du Y; Lewis I; Kurtkaya S; Prussia A; Li L; Sneed B; Plemper RK
• Design, synthesis and biological evaluation of bridged epothilone D analogues.
  Org Biomol Chem Volume: 6 Page(s): 4542 - 4552
  12/21/2008 Authors: Chen Q-H; Ganesh T; Brodie P; Slebodnick C; Jiang Y; Banerjee A; Bane S; Snyder JP; Kingston DGI
• Synthesis and SAR study of N-(4-hydroxy-3-(2-hydroxynaphthalene-1-yl)phenyl)-arylsulfonamides: heat shock protein 90 (Hsp90) inhibitors with submicromolar activity in an in vitro assay.
  Bioorg Med Chem Lett Volume: 18 Page(s): 4982 - 4987
  09/15/2008 Authors: Ganesh T; Thepchatri P; Li L; Du Y; Fu H; Snyder JP; Sun A
• ORGN 106-Design, synthesis and biological evaluation of C4-C9 bridged epothilone B and D analogs
  Volume: 236
  08/17/2008 Authors: Jiang Y; Ganesh T; Brodie PJ; Bane S; Kingston DGI; Liotta DC; Snyder JP
• Discovery of aminoquinolines as a new class of potent inhibitors of heat shock protein 90 (Hsp90): Synthesis, biology, and molecular modeling.
  Bioorg Med Chem Volume: 16 Page(s): 6903 - 6910
  07/15/2008 Authors: Ganesh T; Min J; Thepchatri P; Du Y; Li L; Lewis I; Wilson L; Fu H; Chiosis G; Dingledine R
• Enhanced microtubule binding and tubulin assembly properties of conformationally constrained paclitaxel derivatives.
  Biochemistry Volume: 46 Page(s): 11514 - 11527
  10/16/2007 Authors: Shanker N; Kingston DGI; Ganesh T; Yang C; Alcaraz AA; Geballe MT; Banerjee A; McGee D; Snyder JP; Bane S
• Improved biochemical strategies for targeted delivery of taxoids.
  Bioorg Med Chem Volume: 15 Page(s): 3597 - 3623
  06/01/2007 Authors: Ganesh T
• Evaluation of the tubulin-bound paclitaxel conformation: synthesis, biology, and SAR studies of C-4 to C-3' bridged paclitaxel analogues.
  J Med Chem Volume: 50 Page(s): 713 - 725
  02/22/2007 Authors: Ganesh T; Yang C; Norris A; Glass T; Bane S; Ravindra R; Banerjee A; Metaferia B; Thomas SL; Giannakakou P
• Promotion of tubulin assembly by poorly soluble taxol analogs.
  Anal Biochem Volume: 360 Page(s): 56 - 62
  01/01/2007 Authors: Sharma S; Ganesh T; Kingston DGI; Bane S
• Design, synthesis, and bioactivity of simplified paclitaxel analogs based on the T-Taxol bioactive conformation.
  Bioorg Med Chem Volume: 14 Page(s): 3447 - 3454
  05/15/2006 Authors: Ganesh T; Norris A; Sharma S; Bane S; Alcaraz AA; Snyder JP; Kingston DGI
• Design, synthesis and biological investigation of conformationally constrained epothilone D analogs
  Volume: 231
  03/26/2006 Authors: Ganesh T; Brodie P; Bane S; Sharma S; Ravindra R; Snyder JP; Kingston DGI
• Computational analysis of T-Taxol and highly modified taxane analogs
  Volume: 231
  03/26/2006 Authors: Alcaraz AA; Ganesh T; Yang C; Sharma S; Norris A; Mehta AK; Bane S; Kingston DGI; Snyder JP
• Design, synthesis, and bioactivity of simplified paclitaxel analogs based on the T-Taxol bioactive conformation
  Volume: 229 Page(s): U160 - U160
  03/13/2005 Authors: Ganesh T; Norris A; Sharma S; Bane S; Lakdawala AS; Snyder JP; Kingston DGI
• Evaluation of the bioactive tubuilin-binding paclitaxel conformation: Synthesis and biological evaluation of C4 to C3 '-phenyl bridged paclitaxel analogs.
  Volume: 229 Page(s): U193 - U193
  03/13/2005 Authors: Ganesh T; Bane S; Ravindra R; Shanker N; Lakdawala AS; Snyder JP; Norris A; Kingston DGI
• Microtubule binding, stabilization and cytotoxicities of conformationally constrained taxol derivatives
  Volume: 15 Page(s): 294A - 294A
  11/01/2004 Authors: Shanker N; Ravindra R; Ganesh T; Morris A; Lakdawala AS; Giannakakou A; Thomas S; Kingston DG; Snyder JP; Bane SL
• The bioactive Taxol conformation on beta-tubulin: experimental evidence from highly active constrained analogs.
  Proc Natl Acad Sci U S A Volume: 101 Page(s): 10006 - 10011
  07/06/2004 Authors: Ganesh T; Guza RC; Bane S; Ravindra R; Shanker N; Lakdawala AS; Snyder JP; Kingston DGI
• Taxol pharmacophore: Experimental evidence from a highly constrained analog and REDOR NMR.
  Volume: 227 Page(s): U41 - U41
  03/28/2004 Authors: Kingston DGI; Ganesh T; Schilling JK; Guza RC; Bane S; Shanker N; Ravindra R; Snyder JP; Lakdawala A; Cegelski L
• Synthesis and biological evaluation of fluorescently labeled epothilone analogs for tubulin binding studies.
  Volume: 226 Page(s): U49 - U49
  09/01/2003 Authors: Ganesh T; Kingston DGI; Bane S; Shanker N; Schilling JK
• Asymmetric synthesis of the putative structure of (-)-oryzoxymycin.
  Org Lett Volume: 5 Page(s): 239 - 242
  02/06/2003 Authors: Bunnage ME; Ganesh T; Masesane IB; Orton D; Steel PG
• Kinetic resolution of (+/-)-trans-3-acetoxy-2-phenyl-1,5-benzodioxapine by pig liver acetone powder
  INDIAN JOURNAL OF CHEMISTRY SECTION B-ORGANIC CHEMISTRY INCLUDING MEDICINAL CHEMISTRY Volume: 38 Page(s): 397 - 399
  04/01/1999 Authors: Ganesh T; Sharma KK; Krupadanam GLD
• A facile synthesis of 2-hydroxy-2-aryl 1,4-benzodioxanes
  SYNTHETIC COMMUNICATIONS Volume: 29 Page(s): 2069 - 2078
  01/01/1999 Authors: Ganesh T; Kumar CH; Krupadanam GLD
• A new synthesis of heterocyclic compounds with 1,5-benzodioxapine, 1,5-benzodiazepine, 1,5-benzothiazepine ring systems
  INDIAN JOURNAL OF CHEMISTRY SECTION B-ORGANIC CHEMISTRY INCLUDING MEDICINAL CHEMISTRY Volume: 37 Page(s): 34 - 38
  01/01/1998 Authors: Ganesh T; Krupadanam GLD